Value-Based Care Contracting for Pharmacy Drugs: Opportunity for the United States
Value in Health · 2026-10
DOI: 10.1016/j.jval.2026.08.014 ↗Kurz gefasst
Editorial in der Zeitschrift Value in Health, 2026-10. Verfasst von Urvish Jain und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bennett School of Public Policy, University of Cambridge, Cambridge, England, UK. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
The onset of improved data interoperability required as a result of the 21st Century Cures Act, 92% Health Information Exchange coverage, and lessons learned from European pharmaceutical risk-sharing models present innovative and timely opportunities for the United States to adopt pharmaceutical value-based contracting (VBC), which uses drug-level performance to allocate financial risk between payers and manufacturers based on clinical and economic metrics. Having been piloted in Italy, Spain, and the United Kingdom, this analysis explores different contracting options and paths for organizations such as the Centers for Medicare and Medicaid Services and integrated payer-provider networks to draw on these lessons to adapt VBC frameworks to the US pharmaceutical landscape. Although advances have been seen in other areas of VBC and rising net drug costs year-over-year, only 2.3% of publicly available pharmaceutical VBC contracts have been deployed in the United States compared with 77.9% in Europe. As such, we present a path forward for the expansion of VBC to promote orphan drug development, expand access to pharmaceuticals, and improve patient safety.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bennett School of Public Policy, University of Cambridge, Cambridge, England, UK.
- Stanford University School of Medicine, Palo Alto, CA, USA.
- Washington University in St Louis, St Louis, MO, USA.
- Emory Health Plan, Atlanta, GA, USA.
- Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto, CA, USA. Electronic address: andrewparambath@gmail.com.
Zitieren
APA
Jain, U., Polkampally, S., Jadav, A. A., Jain, B., Jain, P., Haumschild, R., & Parambath, A. (2026). Value-Based Care Contracting for Pharmacy Drugs: Opportunity for the United States. Value in Health. https://doi.org/10.1016/j.jval.2026.08.014
Vancouver
Jain U, Polkampally S, Jadav AA, Jain B, Jain P, Haumschild R, et al. Value-Based Care Contracting for Pharmacy Drugs: Opportunity for the United States. Value in Health. 2026. doi:10.1016/j.jval.2026.08.014
BibTeX
@article{Jain2026,
author = {Jain, Urvish and Polkampally, Srinidhi and Jadav, Arnav Ajay and Jain, Bhav and Jain, Pankaj and Haumschild, Ryan and Parambath, Andrew},
title = {Value-Based Care Contracting for Pharmacy Drugs: Opportunity for the United States},
journal = {Value in Health},
year = {2026},
doi = {10.1016/j.jval.2026.08.014}
}
EUVIMED